Latest news
FDA grants Lilly’s Olomorasib breakthrough therapy status in rare pancreatic cancer fight - Indian Pharma PostIndian Pharma Post · Wed, 05 Aug 2026 14:18:22 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMTEli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Is The Stock Still Cheap? - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 05:13:10 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -Pharmaceutical Business review - · Tue, 04 Aug 2026 19:15:28 GMTOlomorasib Earns FDA Breakthrough Therapy in KRAS G12C+ Pancreatic Cancer - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:38:44 GMTEli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer - simplywall.stsimplywall.st · Tue, 04 Aug 2026 15:17:34 GMTLilly’s olomorasib gets FDA Breakthrough Therapy designation for pancreatic cancer - PMLiVEPMLiVE · Tue, 04 Aug 2026 10:55:00 GMTEli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Backs $70 Million Raise - Yahoo FinanceYahoo Finance · Mon, 03 Aug 2026 21:08:39 GMT